Shire share price: Pharmco faces criticism over pay policy

Shire (LON:SHP) faces criticism over its executive pay policy from a leading investor advisory group, Reuters has reported. The news comes ahead the pharmco’s annual general meeting (AGM) next week.

Shire’s share price has been little changed in London this morning, having inched 0.18 percent higher to 3,628.00p as of 1029 BST. The pharmco’s shares are underperforming the broader UK market, with the benchmark FTSE 100 index currently standing 0.76 percent higher at 7,281.14 points. The group’s shares have lost about 18 percent of their value over the past year, as compared with a near two-percent rise in the Footsie.

Shire criticised over pay policy

Reuters reported this morning that Pensions & Investment Research Consultants (PIRC), which advises pension funds and others how to vote at AGMs, believed that Shire’s chief executive Flemming Ornskov’s maximum potential bonus was ‘excessive’ at 780 percent of salary, even though he took a pay cut last year.

The newswire notes, however, that two other shareholder advisory groups, ISS and Glass Lewis, had recommended votes in favour of all of Shire’s 2018 AGM proposals, including the CEO’s pay.

Crunch week ahead

The news comes at a sensitive time for Shire, whose AGM meeting is due on April 24, just a day before Japan’s Takeda Pharmaceuticals has to decide whether to make a bid for the London-listed rare disease specialist. The FTSE 100 group then is due to report its first-quarter results on April 26.

Earlier this week, the London-listed rare disease specialist inked a deal to sell its oncology business for $2.4 billion.

As of April 13, the consensus forecast amongst 20 polled investment analysts covering Shire for the Financial Times has it that the company will outperform the market.

Risk Warning: Investing in digital currencies, stocks, shares and other securities, commodities, currencies and other derivative investment products (e.g. contracts for difference (“CFDs”) is speculative and carries a high level of risk. Each investment is unique and involves unique risks.

CFDs and other derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how an investment works and whether you can afford to take the high risk of losing your money.

Cryptocurrencies can fluctuate widely in prices and are, therefore, not appropriate for all investors. Trading cryptocurrencies is not supervised by any EU regulatory framework. Past performance does not guarantee future results. Any trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Your capital is at risk.

When trading in stocksyour capital is at risk.

Past performance is not an indication of future results. Trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Prices may go down as well as up, prices can fluctuate widely, you may be exposed to currency exchange rate fluctuations and you may lose all of or more than the amount you invest. Investing is not suitable for everyone; ensure that you have fully understood the risks and legalities involved. If you are unsure, seek independent financial, legal, tax and/or accounting advice. This website does not provide investment, financial, legal, tax or accounting advice. Some links are affiliate links. For more information please read our full risk warning and disclaimer.

I certify that this review is based on my own experience and is my genuine opinion of this provider, and that I have no personal or business relationship with this establishment, and have not been offered any incentive or payment originating from the establishment to write this review. I understand that iNVEZZ has a zero-tolerance policy on fake reviews.

Writing great reviews helps others discover the providers that are just right for them. Here are a few tips:

Be informative and insightful: Be specific and relevant to the provider you’re reviewing, and describe what other users are likely to experience.

Keep it real: Be authentic. Review your own experience, and explain why you liked or disliked the provider. Try to be as accurate as possible, and include both the positive and negative aspects of your experience.

Be respectful: Not every experience with a particular provider is going to be perfect. Sometimes you’ll want to share negative feedback. Even if you’re frustrated, make sure your criticism is constructive. Business owners often use feedback to improve their offerings.

Write with style: People will pay attention when you write thoughtful reviews. Keep them readable and avoid excessive capitalization or punctuation. Use good grammar, check your spelling, and avoid profanity. Choose the right length - a paragraph is great. Be creative and have fun!

Filter

KPIs

Customize

Report review

What is the issue?

Upload photo

Crop photo

Insert link

URL

Anchor text

Upload photo

iNVEZZ SWOT explained

Welcome back! It seems that last time you subscribed for Royal Mail alerts.

Since you’re just one step away from all the good stuff, here’s just a few of the reasons why you might consider becoming an iNVEZZ member: